Functional analysis of the p53 codon 72 polymorphism in black South Africans with rheumatoid arthritis-A pilot study

Clinical Rheumatology

Volumn 29, Issue 10, 2010, Pages 1099-1105

  Moodley, Devapregasan ^a   Mody, Girish M ^b   Chuturgoon, Anil A ^a  

^a University of KwaZulu Natal Faculty of Health Sciences   (South Africa)

^b UNIVERSITY OF KWAZULU NATAL   (South Africa)

Author keywords

Apoptosis; Mitochondrial depolarization; P53; Polymorphism; Rheumatoid arthritis

Indexed keywords

PROTEIN P53;

ADOLESCENT; ADULT; AGED; ALLELE; APOPTOSIS; ARTICLE; FEMALE; FLOW CYTOMETRY; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; HUMAN; LYMPHOCYTE; MALE; METABOLISM; MIDDLE AGED; NEGRO; PILOT STUDY; POLYMERASE CHAIN REACTION; RHEUMATOID ARTHRITIS; SOUTH AFRICA;

ADOLESCENT; ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; AGED; ALLELES; APOPTOSIS; ARTHRITIS, RHEUMATOID; FEMALE; FLOW CYTOMETRY; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; LYMPHOCYTES; MALE; MIDDLE AGED; PILOT PROJECTS; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; SOUTH AFRICA; TUMOR SUPPRESSOR PROTEIN P53;

EID: 79952109897     PISSN: 07703198     EISSN: 14349949     Source Type: Journal    
DOI: 10.1007/s10067-010-1505-4     Document Type: Article

References (35)

1. Vousden KH, Lu X (2002) Live or let die: the cell's response to p53. Nat rev 2(8):594-604
2. Vousden KH (2006) Outcomes of p53 activation-spoilt for choice. J Cell Sci 119(Pt 24):5015-5020
3. Caelles C, Helmberg A, Karin M (1994) p53-dependent apoptosis in the absence of transcriptional activation of p53-Target genes. Nature 370(6486):220-223
4. Haupt Y, Rowan S, Shaulian E, Vousden KH, Oren M (1995) Induction of apoptosis in HeLa cells by trans-Activation-deficient p53. Genes Dev 9(17):2170-2183
5. Vaseva AV, Moll UM (2009) The mitochondrial p53 pathway. Biochim Biophys Acta 1787(5):414-420
6. Marchenko ND, Zaika A, Moll UM (2000) Death signal-induced localization of p53 protein to mitochondria. A potential role in apoptotic signaling. J Biol Chem 275(21):16202-16212
7. Sakamuro D, Sabbatini P, White E, Prendergast GC (1997) The polyproline region of p53 is required to activate apoptosis but not growth arrest. Oncogene 15(8):887-898
8. Walker KK, Levine AJ (1996) Identification of a novel p53 functional domain that is necessary for efficient growth suppression. Proc Natl Acad Sci USA 93(26):15335-15340
9. Matlashewski GJ, Tuck S, Pim D, Lamb P, Schneider J, Crawford LV (1987) Primary structure polymorphism at amino acid residue 72 of human p53. Mol Cell Biol 7(2):961-963
10. Harris N, Brill E, Shohat O, Prokocimer M, Wolf D, Arai N, Rotter V (1986) Molecular basis for heterogeneity of the human p53 protein. Mol Cell Biol 6(12):4650-4656
11. Buchman VL, Chumakov PM, Ninkina NN, Samarina OP, Georgiev GP (1988) A variation in the structure of the proteincoding region of the human p53 gene. Gene 70(2):245-252
12. Storey A, Thomas M, Kalita A, Harwood C, Gardiol D, Mantovani F, Breuer J, Leigh IM, Matlashewski G, Banks L (1998) Role of a p53 polymorphism in the development of human papillomavirus-Associated cancer. Nature 393(6682):229-234
13. Thomas M, Kalita A, Labrecque S, Pim D, Banks L, Matlashewski G (1999) Two polymorphic variants of wildtype p53 differ biochemically and biologically. Mol Cell Biol 19(2):1092-1100
14. Dumont P, Leu JI, Della Pietra AC, 3rd George DL, Murphy M (2003) The codon 72 polymorphic variants of p53 have markedly different apoptotic potential. Nature genetics 33(3):357-365
15. Elmore S (2007) Apoptosis: a review of programmed cell death. Toxicol Pathol 35(4):495-516
16. Moodley D, Mody G, Patel N, Chuturgoon AA (2008) Mitochondrial depolarisation and oxidative stress in rheumatoid arthritis patients. Clin Biochem 41(16-17):1396-1401
17. Lee YH, Kim YR, Ji JD, Sohn J, Song GG (2001) p53 codon 72 polymorphism and rheumatoid arthritis. J Rheumatol 28 (11):2392-2394
18. Macchioni P, Nicoli D, Casali B, Catanoso M, Farnetti E, Boiardi L, Salvarani C (2007) The codon 72 polymorphic variants of p53 in Italian rheumatoid arthritis patients. Clin Exp Rheumatol 25 (3):416-421
19. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS et al (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31(3):315-324
20. Gay S, Kuchen S, Gay RE, Neidhart M (2002) Cartilage destruction in rheumatoid arthritis. Ann Rheum Dis 61(Suppl 2):ii87
21. Hamilton JA (1983) Hypothesis: in vitro evidence for the invasive and tumor-like properties of the rheumatoid pannus. J Rheumatol 10(6):845-851
22. Muller-Ladner U, Kriegsmann J, Gay RE, Gay S (1995) Oncogenes in rheumatoid arthritis. Rheum Dis Clin N Am 21 (3):675-690
23. Yee KS, Vousden KH (2005) Complicating the complexity of p53. Carcinogenesis 26(8):1317-1322
24. Firestein GS, Nguyen K, Aupperle KR, Yeo M, Boyle DL, Zvaifler NJ (1996) Apoptosis in rheumatoid arthritis: p53 overexpression in rheumatoid arthritis synovium. Am J Pathol 149 (6):2143-2151
25. Firestein GS, Echeverri F, Yeo M, Zvaifler NJ, Green DR (1997) Somatic mutations in the p53 tumor suppressor gene in rheumatoid arthritis synovium. Proc Natl Acad Sci USA 94(20):10895-10900
26. Hainaut P, Hernandez T, Robinson A, Rodriguez-Tome P, Flores T, Hollstein M, Harris CC, Montesano R (1998) IARC Database of p53 gene mutations in human tumors and cell lines: updated compilation, revised formats and new visualisation tools. Nucleic Acids Res 26(1):205-213
27. Hainaut P, Soussi T, Shomer B, Hollstein M, Greenblatt M, Hovig E, Harris CC, Montesano R (1997) Database of p53 gene somatic mutations in human tumors and cell lines: updated compilation and future prospects. Nucleic Acids Res 25(1):151-157
28. Kullmann F, Judex M, Neudecker I, Lechner S, Justen HP, Green DR, Wessinghage D, Firestein GS, Gay S, Scholmerich J et al (1999) Analysis of the p53 tumor suppressor gene in rheumatoid arthritis synovial fibroblasts. Arthritis Rheum 42 (8):1594-1600
29. Tak PP, Zvaifler NJ, Green DR, Firestein GS (2000) Rheumatoid arthritis and p53: how oxidative stress might alter the course of inflammatory diseases. Immunol Today 21(2):78-82
30. Dai S, Mao C, Jiang L, Wang G, Cheng H (2009) P53 polymorphism and lung cancer susceptibility: a pooled analysis of 32 case-control studies. Hum Genet 125(5-6):633-638
31. Sul J, Yu GP, Lu QY, Lu ML, Setiawan VW, Wang MR, Guo CH, Yu SZ, Mu L, Cai L et al (2006) P53 Codon 72 polymorphisms: a case-control study of gastric cancer and potential interactions. Cancer Lett 238(2):210-223
32. Biros E, Kohut A, Biros I, Kalina I, Bogyiova E, Stubna J (2002) A link between the p53 germ line polymorphisms and white blood cells apoptosis in lung cancer patients. Lung cancer (Amsterdam, Netherlands) 35(3):231-235
33. Bonafe M, Salvioli S, Barbi C, Mishto M, Trapassi C, Gemelli C, Storci G, Olivieri F, Monti D, Franceschi C (2002) p53 codon 72 genotype affects apoptosis by cytosine arabinoside in blood leukocytes. Biochem Biophys Res Commun 299(4):539-541
34. Bonafe M, Salvioli S, Barbi C, Trapassi C, Tocco F, Storci G, Invidia L, Vannini I, Rossi M, Marzi E et al (2004) The different apoptotic potential of the p53 codon 72 alleles increases with age and modulates in vivo ischaemia-induced cell death. Cell Death Differ 11(9):962-973
35. Salvioli S, Bonafe M, Barbi C, Storci G, Trapassi C, Tocco F, Gravina S, Rossi M, Tiberi L, Mondello C et al (2005) p53 codon 72 alleles influence the response to anticancer drugs in cells from aged people by regulating the cell cycle inhibitor p21WAF1. Cell Cycle 4(9):1264-1271